SELVAS Healthcare, Inc.
Research SELVAS Healthcare, Inc. (208370.KQ) on Bullrun: market cap KRW 61.72B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker208370.KQ
- ExchangeKQ
- CountrySouth Korea
- SectorHealthcare
- IndustryMedical Devices
- CurrencyKRW
- Market capKRW 61.72B
- Financial periodQ2 2026
- RevenueKRW 8.20B
- Net income-KRW 8.68B
- Free cash flow-KRW 877.66M
- Gross margin50.4%
Valuation Snapshot
latest market cap is KRW 61.72B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 61.72B | n/a | n/a | n/a |
Dividend history
About SELVAS Healthcare, Inc.
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The company provides daisy players, handheld, and desktop magnifiers.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is SELVAS Healthcare, Inc.'s market cap?
SELVAS Healthcare, Inc.'s market capitalization is KRW 61.72B.
What does SELVAS Healthcare, Inc. do?
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The company provides daisy players, handheld, and desktop magnifiers.